Results

Total Results: 925 records

Showing results for "failure".

41. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
    January 01, 2010 - stroke prevention in patients with AF, and primary prevention of AF and later progression to heart failure … : 02-25-11 2 Staff-Generated PICO: Prevention of Atrial Fibrillation and Progression to Heart Failure … benefits and harms of ACEIs, ARBs and statins in the prevention of new AF and progression of AF to heart failure … treatment of AF, (2) stroke prevention in AF, and (3) primary prevention of AF and progression to heart failure … The area of prevention, with regards to both prevention of AF and then progression to heart failure,

42. The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment Endpoints (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/mcda-johnson.pdf
    August 27, 2012 - of a fracture 5.0 3.9 3.4 3.8 Highlighted data: 5-year treatment – related risk of a renal failure … Weight of evidence Fracture risk Fracture Risk 5-year treatment – related risk of a renal failure … Bar chart showing 3 month, 5-month, and 10-month progression-free survival rates and chance of liver failure … Bar chart showing 3 month, 5-month, and 10-month progression-free survival rates and chance of liver failure … Bar chart showing 3 month, 5-month, and 10-month progression-free survival rates and chance of liver failure

43. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
    December 20, 2011 - Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. … NICE Clinical Guideline 108: Chronic heart failure: Management of chronic heart failure in adults in … B-type natriuretic peptide-guided heart failure therapy: A meta-analysis. … Long-term clinical variation of NT-proBNP in stable chronic heart failure patients. … The Seattle Heart Failure Model: Prediction of survival in heart failure.

44. Omega-3 Fatty Acids and Cardiovascular Disease: A Review of the Research for Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_consumer.pdf
    July 01, 2017 - fatty acids affect longer term cardiovascular problems such as the risk of heart attack, heart failure … This is the main cause of heart attacks and heart failure. … supplements ALA dietary supplements The risk of longer term CV problems (such as heart attack and heart failure … fatty acids: – Appears to lower the risk of longer term CV problems (such as heart attack and heart failure … supplements: – Do not lower the risk of longer term CV problems (such as heart attack and heart failure

45. Atrial-Fibrillation-Addendum-140619 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-addendum-140619.pdf
    June 19, 2014 - procedural rhythm-control therapies Treatment Restorati Maintenance Recurrence of All-Cause and CV/AF Heart Failure …   Treatment Restorati Maintenance Recurrence of All-Cause and CV/AF Heart Failure …   Treatment Restorati Maintenance Recurrence of All-Cause and CV/AF Heart Failure …   Treatment Restorati Maintenance Recurrence of All-Cause and CV/AF Heart Failure …   Treatment Restorati Maintenance Recurrence of All-Cause and CV/AF Heart Failure

46. Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
    October 01, 2019 - Key Messages • Antibiotic therapy increases the clinical cure rate and reduces the clinical failure … • Oral and intravenous corticosteroids improve dyspnea and reduce the clinical failure rate. … antibiotics, 5-lipoxygenase inhibitor, and statins on mortality, dyspnea, need for intubation, clinical failure … intubation, repeat exacerbation and/or hospital readmissions and ECOPD resolution (clinical cure, failure … Failure to detect statistical significance for most of the outcomes may have resulted from type II

47. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
    February 01, 2013 - , repeat hospitalization, length of hospital stay, graft failure, angina relief, quality of life, or … , repeat hospitalization, length of hospital stay, graft failure, angina relief, quality of life, or … , repeat hospitalization, length of hospital stay, graft failure, angina relief, quality of life, or … , repeat hospitalization, length of hospital stay, graft failure, angina relief, quality of life, or … , repeat hospitalization, length of hospital stay, graft failure, angina relief, quality of life, or

48. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
    May 22, 2012 - twice that of patients without AF, but AF can result in myocardial ischemia or even infarction, heart failure … Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure … Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from … the Valsartan Heart Failure Trial (Val-HeFT). … Rhythm control versus rate control for atrial fibrillation and heart failure.

49. COPD is common and respiratory failure due to COPD is an increasingly common disorder. Use of non-invasive positive pressure ventilation (NPPV) for patients with respiratory failure due to exacerbatons of COPD. Several trials and… | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/copd-is-common-and-respiratory-failure-due-to-copd-is-an-increasingly-common-disorder-use-of-non-invasive-positive-pressure-ventilation-nppv-for-patients-with-respiratory-failure-due-to-exacerbatons-of-copd-several-trials-an

50. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
    January 01, 2007 - For instance, biguanides such as metformin are contraindicated in patients with renal or liver failure … ; congestive heart failure (CHF); severe lactic acidosis; cancer; anemia, thrombocytopenia, or leucopenia … Elevated aminotransferase levels/liver failure. … Congestive heart failure. … Congestive NA Thiazolidinediones had greater risk of CHF compared with heart failure (CHF) metformin

51. Update Topic Brief CER 27 NSD FINAL_SJ final (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
    January 17, 2014 - § Hypoglycemia § Liver injury § Congestive heart failure § Severe lactic acidosis § Cancer … e.g. increased risk of bladder cancer), the combination of pioglitazone with insulin (e.g. cardiac failure

52. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
    October 01, 2009 - support the use of angiotensin converting enzyme (ACE) inhibitors in patients who have chronic heart failure … inhibitor and ARB in post- myocardial-infarction patients with left ventricular dysfunction or heart failure … Hospitalization for High • ACE inhibitor therapy is better than placebo in heart failure patients with … Hospitalization Moderate • Combination of ACE inhibitor + ARB (ramipril + for heart failure telmisartan … (ARB for heart failure therapy not evaluated.

53. Evidence Summary: Management of Colonic Diverticulitis (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-233-diverticulitis-evidence-summary.pdf
    October 01, 2020 - SoE), but there is insufficient evidence regarding important clinical outcomes, including treatment failure … outpatient management of patients with uncomplicated diverticulitis leads to higher rates of treatment failure … Evidence regarding dDeath, treatment failure, diverticulitis-related morbidities, rehospitalization, … high SoE that procedural complications are rare (fewer than 1% of patients) and that colonoscopy failure

54. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
    February 01, 2009 - 120 days since APM initiation: acute myocardial infarction, cerebrovascular events, congestive heart failure … In the FDA’s analysis, heart-related events (heart failure and sudden death) and infections (mostly … selection bias among prevalent users from early symptom emergence, drug intolerance, or treatment failure … Hospitalization with a diagnostic code for congestive heart failure.27 Pneumonia. … Comparison of coding of heart failure and comorbidities in administrative and clinical data for use

55. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
    October 27, 2009 - ptosis • refractive changes • tinnitus • Arrhythmia • Bradycardia • cardiac arrest • cardiac failure … characterized by dyspnea, bronchospasm • thickened bronchial secretions • asthma • respiratory failure … Hypotension • Syncope • heart block • cerebral vascular accident • cerebral ischemia • cardiac failure … ptosis • decreased corneal sensitivity • cystoid macular edema • visual disturbances • cardiac failure … chest pain • Syncope • heart block • cerebral vascular accident • cerebral ischemia • cardiac failure

56. Microsoft Word - finapps.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
    January 01, 2007 - Stenting of renal artery stenosis: is it beneficial in chronic renal failure? … Adj BP Δ = -34/-11 (adjusted for followup time) 6 mo SCr Δ = +0.01 Final SCr Δ = +0.11 “Renal failure … Adj BP Δ = -8/-1 P=0.02 (net) 6 mo SCr Δ = +0.10 NS (net) Final SCr Δ = +0.05 NS (net) “Renal failure … D -5 M Among 12 patients, “9 angioplasties (1 failure) and 1 bilateral stent. 4 kidneys had... surgery … T Baseline value among those with clinical failure (n=13). U Median.

57. Executive Summary: Pain Management Interventions for Hip Fracture (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer30_hip-fracture-pain-executive-summary_20110517.pdf
    May 01, 2011 - ­day), and the incidence of serious adverse effects (e.g., delirium, myocardial infarction, renal failure … weaknesses in the design of the studies included lack of independent blind outcome assessment and failure … day]), and the incidence of serious adverse effects (i.e., delirium, myocardial infarction, renal failure … data Delirium None Insufficient No data Myocardial infarction None Insufficient No data Renal failure … pain management Insufficient No significant difference vs. standard care (1 cohort study) Renal failure

58. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - Six months of combination therapy reduced clinical failure, biochemical failure, or death from any … Long- term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. … Freedom from biochemical failure. … the treatment arms for biochemical failure, any failure, or late side effects. … Six months of combination therapy reduced clinical failure, biochemical failure, or death from any

59. Untitled (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
    July 06, 2015 - What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, … Heart failure with preserved ejection fraction: a clinical dilemma. … Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. … Cardiaca-Heart Failure, I. (2012). … programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).

60. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - Six months of combination therapy reduced clinical failure, biochemical failure, or death from any … Long- term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. … Freedom from biochemical failure. … the treatment arms for biochemical failure, any failure, or late side effects. … Six months of combination therapy reduced clinical failure, biochemical failure, or death from any